Failure of periconceptual folic acid to prevent a neural tube defect in the offspring of a mother taking sodium valproate

References

References

1. • Lindhout D.
   • Meinardi H.
   Spina bifida and in utero exposure to valproate.
   Lancet. 1994; 343: 396
   • Google Scholar
2. • MRC Vitamin Study Research Group
   Prevention of neural tube defects: results of the Medical Research Council Vitamin Study.
   Lancet. 1991; 338: 131-137
   • Scopus (3563)
   • PubMed
   • Abstract
   • Google Scholar
3. • Clayton-Smith J.
   • Donnai D.
   Fetal valproate syndrome.
   Journal of Medical Genetics. 1995; 32: 724-727
   • Scopus (134)
   • PubMed
   • Crossref
   • Google Scholar
4. • Van Allen M.I.
   • Kalousek D.K.
   • Chernoff G.F.
   • et al.
   Evidence for multi-site closure of the neural tube in humans.
   American Journal of Medical Genetics. 1993; 47: 723-743
   • Scopus (322)
   • PubMed
   • Crossref
   • Google Scholar
5. • Trotz M.
   • Wegner S.
   • Nau H.
   Valproic acid-induced neural tube defects: Reduction by folinic acid in the mouse.
   Life Sciences. 1987; 41: 103-110
   • Scopus (76)
   • PubMed
   • Crossref
   • Google Scholar
6. • Elmazar M.M.A.
   • Thiel T.
   • Nau H.
   Effect of supplementation with folinic acid, vitamin B6, and vitamin B12 on valproic acid-induced teratogenesis in mice.
   Fundamental Applied Toxicology. 1992; 18: 389-394
   • Scopus (53)
   • PubMed
   • Crossref
   • Google Scholar
7. • Essien F.B.
   • Wannberg S.L.
   Methionine but not folinic acid or vitamin B12 alters the frequency of neural tube defects in Axd mutant mice.
   Journal of Nutrition. 1993; 123: 27-34
   • Scopus (92)
   • PubMed
   • Google Scholar
8. • Hansen D.K.
   • Grafton T.F.
   • Dial S.L.
   • Gehring T.A.
   • Sitonen P.H.
   Effect of supplemental folic acid on valproic acid-induced embryotoxicity and tissue zinc levels in vivo.
   Teratology. 1995; 52: 277-285
   • Scopus (40)
   • PubMed
   • Crossref
   • Google Scholar
9. • Dansky L.V.
   • Rosenblatt D.A.
   • Andermann E.
   Mechanisms of teratogenesis: folic acid and antiepileptic therapy.
   Neurology. 1992; 42 (Suppl. 5): 32-42
   • Google Scholar
10. • Kishi T.
    • Fujita N.
    • Eguchi T.
    • Ueda K.
    Mechanism for the reduction of serum folate by antiepileptic drugs during prolonged therapy.
    Journal of Neurological Science. 1997; 145: 109-112
    • Scopus (103)
    • PubMed
    • Abstract
    • Full Text
    • Full Text PDF
    • Google Scholar
11. • Centers for Disease Control
    Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects.
    Morbidity Mortality Weekly Report. 1992; 41: 1-7
    • Google Scholar
12. • Werler M.W.
    • Schapiro S.
    • Mitchell A.A.
    Periconceptual folic acid exposure and risk of occurrent neural-tube defects.
    Journal of the American Medical Association. 1993; 269: 1257-1261
    • Scopus (498)
    • PubMed
    • Crossref
    • Google Scholar
13. • Daly S.
    • Mills J.L.
    • Molloy A.M.
    • et al.
    Minimum effective dose of folic acid for food fortification to prevent neural tube defects.
    Lancet. 1997; 350: 1666-1669
    • Scopus (243)
    • PubMed
    • Abstract
    • Full Text
    • Full Text PDF
    • Google Scholar
14. • Czeizel A.E.
    • Dudas I.
    Prevention of the first occurrence of neural tube defects by periconceptual vitamin supplementation.
    New England Journal of Medicine. 1992; 327: 1832-1835
    • Scopus (2679)
    • PubMed
    • Crossref
    • Google Scholar